|
Q1 2020
Filed on May 13, 2020
|
221,196
|
N/A
|
|
|
Q1 2020
Filed on May 13, 2020
|
11,308
|
$1.43 - $4.36
$16.2K - $49.3K
|
|
|
Q1 2020
Filed on May 13, 2020
|
75,448
|
N/A
|
|
|
Q1 2020
Filed on May 13, 2020
|
278,584
|
$13.01 - $37.4
$3.62M - $10.4M
|
|
Alaska Communications Sys Gr
|
Q1 2020
Filed on May 13, 2020
|
1,055,500
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
54,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
67,550,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
123,152
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
2,771,620
|
N/A
|
|
Alder Biopharmaceuticals Inc
|
Q4 2019
Filed on Feb 12, 2020
|
725,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
1,934,390
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
884,534
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
27,821
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
3,014,134
|
$7.8 - $14.72
$23.5M - $44.4M
|
|
Marinus Pharmaceuticals Inc
|
Q4 2019
Filed on Feb 12, 2020
|
2,430,518
|
N/A
|
|
Legacy Tex Finl Group Inc
|
Q4 2019
Filed on Feb 12, 2020
|
425,376
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
96,400
|
N/A
|
|
Tortoise Essential Assets In
|
Q4 2019
Filed on Feb 12, 2020
|
10,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
23,675
|
$5.56 - $8.99
$132K - $213K
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
12,823
|
$26.25 - $34.02
$337K - $436K
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
240,000
|
$4.69 - $6.52
$1.13M - $1.56M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
56,305
|
$13.07 - $17.94
$736K - $1.01M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
2,600
|
$92.28 - $95.18
$240K - $247K
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
4,375,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
629,997
|
N/A
|
|
Brookfield Property Reit Inc
|
Q4 2019
Filed on Feb 12, 2020
|
45,891
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
277,900
|
$4.3 - $5.66
$1.19M - $1.57M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
601,005
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
135,576
|
$47.64 - $55.76
$6.46M - $7.56M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
204,823
|
$35.59 - $41.76
$7.29M - $8.55M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
2,291
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
30,179,467
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
11,387
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
301,776
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
30,000,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
2,150
|
$16.45 - $19.6
$35.4K - $42.1K
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
494,121
|
$7.71 - $10.53
$3.81M - $5.2M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
7,671
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
124,571
|
N/A
|
|
Assertio Therapeutics Inc
|
Q4 2019
Filed on Feb 12, 2020
|
2,000,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
1,326,140
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
1,165,690
|
$37.67 - $48.83
$43.9M - $56.9M
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
6,196,642
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
47,418
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
8,366
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
12,253
|
$16.09 - $23.01
$197K - $282K
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
890,664
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
4,789,926
|
N/A
|
|
Audentes Therapeutics Inc
|
Q4 2019
Filed on Feb 12, 2020
|
235,552
|
N/A
|
|
|
Q4 2019
Filed on Feb 12, 2020
|
36,890
|
N/A
|
|